Status:
COMPLETED
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Multiple sclerosis \[MS\] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young...
Eligibility Criteria
Inclusion
- diagnosis of multiple sclerosis
- relapse free in the last 30 days
- being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous 6 months
- ambulate without assistance
- low risk for contraindications for MRI
Exclusion
- moderate or high risk for undertaking strenuous or maximal exercise
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04496804
Start Date
November 2 2020
End Date
November 3 2021
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35209